BRIGHT PEAK - Trademark Details
Status: 700 - Registered
Serial Number
79285070
Registration Number
6610085
Word Mark
BRIGHT PEAK
Status
700 - Registered
Status Date
2022-01-11
Filing Date
2020-03-25
Registration Number
6610085
Registration Date
2022-01-11
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-10-26
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
LAM, HAI-LY HUYNH
Statements
Goods and Services
Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; medical and veterinary preparations, namely, recombinant or chemically synthesized and optimized proteins; preparations for destroying vermin; fungicides, herbicides; biotechnological preparations, namely, recombinant or chemically synthesized and optimized proteins for medical use; enzymes for medical use; enzymes for veterinary use; biological and chemical reagents for medical or veterinary use; amino acids for medical use; amino acids for veterinary use; peptides for medical or veterinary use, namely, for the treatment of cancer, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine diseases, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system, respiratory system, and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; proteins for medical or veterinary use, namely, recombinant or chemically synthesized and optimized proteins for detection and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, autoimmune diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, nutritional diseases, mental and behavioral disorders, diseases of the nervous system, eye and adnexa, ear and mastoid process disorders, diseases of the circulatory system and digestive system, skin and subcutaneous tissue disorders, diseases of the musculoskeletal system and connective tissue, disorders and abnormalities relating to pregnancy and childbirth, certain conditions originating in the puerperium and perinatal periods, congenital malformations and deformations, and chromosomal abnormalities; pharmaceutical preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical compositions and preparations for cancer prevention and treatment; pharmaceutical preparations for treatment of autoimmune and inflammatory diseases; pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for treatment of neurodegenerative, metabolic and ophthalmological diseases
Goods and Services
Advertising; commercial business management; commercial administration; office functions; services provided by commercial business consultants; market analysis, research and development
Goods and Services
Scientific and technological services, namely, scientific research, scientific analysis, and scientific testing in the field of biotechnology and new product research and design services relating thereto; research and development in the field of biotechnology; consulting services in the field of biotechnology; scientific research services in the field of proteins, peptides and antibodies, and scientific advice relating thereto; scientific research services for medical purposes in the field of cancer and autoimmune diseases and scientific advice relating thereto
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-05-08
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-05-08
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Aktiengesellschaft (AG)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Aktiengesellschaft (AG)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Aktiengesellschaft (AG)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Aktiengesellschaft (AG)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Monica Riva Talley
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1529623
International Registration Date
2020-03-25
International Publication Date
2020-05-07
International Renewal Date
2030-03-25
Auto Protection Date
2021-11-07
International Status
001 - Request for extension of protection established
International Status Date
2020-05-07
Priority Claimed In
True
Priority Claimed Date
2019-09-30
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2020-05-07 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2020-05-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-05-12 | APPLICATION FILING RECEIPT MAILED |
| 2020-06-16 | ASSIGNED TO EXAMINER |
| 2020-06-17 | NON-FINAL ACTION WRITTEN |
| 2020-06-18 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2020-07-23 | REFUSAL PROCESSED BY MPU |
| 2020-07-23 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2020-08-07 | REFUSAL PROCESSED BY IB |
| 2021-01-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-01-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-01-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-01-26 | FINAL REFUSAL WRITTEN |
| 2021-01-26 | FINAL REFUSAL E-MAILED |
| 2021-01-26 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2021-07-22 | EXPARTE APPEAL RECEIVED AT TTAB |
| 2021-07-22 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| 2021-07-22 | EX PARTE APPEAL-INSTITUTED |
| 2021-07-22 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2021-07-27 | ASSIGNED TO LIE |
| 2021-07-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-07-29 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-08-24 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-08-24 | EXAMINERS AMENDMENT E-MAILED |
| 2021-08-24 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-08-24 | EXAMINER'S AMENDMENT ENTERED |
| 2021-09-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-09-17 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2021-10-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-10-06 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-10-06 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-10-13 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 2021-10-13 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-10-26 | PUBLISHED FOR OPPOSITION |
| 2021-10-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-11-03 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2021-11-04 | NOTIFICATION PROCESSED BY IB |
| 2022-01-11 | REGISTERED-PRINCIPAL REGISTER |
